DLHCDLH Holdings Corp

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Zachary C. Parker

Location

Georgia, USA

Exchange

Nasdaq

Website

https://dlhcorp.com

Summary

DLH Holdings Corp.

Company Info

CEO

Zachary C. Parker

Location

Georgia, USA

Exchange

Nasdaq

Website

https://dlhcorp.com

Summary

DLH Holdings Corp.

AI Insights for DLHC
5 min read

Quick Summary

DLH Holdings Corp. is a U.S.-based business services company headquartered in Atlanta, Georgia. The company provides technology-enabled business process outsourcing, program management, public health research, data analytics, healthcare support, and logistics services. Its main customers are U.S. federal government agencies, especially defense, veterans’ health, and public health organizations. The company specifically serves customers such as the Department of Veterans Affairs, the Defense Health Agency, the Navy Bureau of Medicine and Surgery, and Army medical research organizations. DLH operates in a contract-driven market where revenue depends heavily on winning, renewing, and performing government service contracts.

Strengths

•

DLH’s primary strength is its specialized position in federal health, defense, and public-sector support services.

•

The company has relationships with important government customers such as the Department of Veterans Affairs, the Defense Health Agency, and military medical organizations.

•

These customers operate in mission-critical areas where experience, compliance, and past performance can matter as much as price.

•

DLH also operates in markets supported by long-term demand for healthcare administration, veterans’ services, defense medical support, and public health analytics.

•

Its relatively low price-to-book valuation could also make the stock interesting to investors who believe the company can return to profitability.

Key Risks

•

DLH faces significant risks from contract concentration, federal budget changes, and competitive bidding pressure.

•

Because the company serves government customers, delays in appropriations, procurement decisions, or contract awards can affect revenue timing.

•

Larger competitors may be able to underbid DLH, offer broader capabilities, or absorb lower margins to win important contracts.

•

The company’s negative earnings and operating losses increase financial risk if performance does not improve.

What to Watch

The provided dataset labels the period as Q4 2026, but that quarter label and the actual filing or earnings-release date should be verified against DLH’s SEC filings or company earnings release before being treated as the confirmed most recent reported quarter.
Based on the supplied financial snapshot, DLH reported operating revenue of approximately $44.2 million, an operating loss of about $3.9 million, a net loss of about $16.8 million, and basic and diluted EPS of -$1.16.
The data also shows interest expense of about $3.1 million and an income tax expense line of about $9.8 million, both of which contributed to the reported loss profile.
No confirmed contract award, backlog update, acquisition, partnership, leadership change, product launch, or formal guidance commentary was included in the provided data.
The dataset lists total gross profit equal to revenue, but this should not be interpreted as a normal 100% gross margin; it may reflect missing or unpopulated cost-of-revenue data in the source.

Price Drivers

•

DLHC’s stock price is likely being driven by profitability concerns, contract visibility, valuation, and expectations for future earnings recovery.

•

The company reported negative basic and diluted EPS of -1.16 and net income of approximately -$16.8 million, which is a major pressure point for investor sentiment.

•

Revenue for the reported financial snapshot was about $44.2 million, and operating income was negative, indicating that margins and cost control are central issues.

•

Valuation metrics such as price-to-book of about 0.56 and EV-to-revenue of about 0.70 may attract value-oriented investors, but only if they believe losses are temporary.

•

The stock’s beta of 1.438 suggests it can move more sharply than the broader market, especially around earnings, contract news, or changes in federal spending expectations.

Recent News

•

Recent news included a Zacks Equity Research article that mentioned DLH Holdings among staffing and services-related companies.

•

In that article, DLH was described as having a Zacks Rank #3, which corresponds to a Hold rating.

•

The same article noted modest estimate increases and projected next-year earnings growth of 72.7%, suggesting some expectation of recovery.

•

Another recent item from ResearchAndMarkets.com discussed Plunkett Research’s Almanac of Middle Market Companies 2025, a broad research resource covering U.S. middle-market companies.

•

That news item appears more informational than company-specific and does not indicate a major DLH transaction, controversy, or contract announcement.

Market Trends

•

DLH is affected by broader trends in federal outsourcing, defense healthcare spending, public health analytics, and government technology modernization.

•

Government agencies continue to need outside contractors for specialized healthcare administration, research support, logistics, and data-driven program management.

•

At the same time, federal contracting remains highly competitive, with large firms pursuing many of the same opportunities as smaller specialists.

•

Labor market conditions also matter because service contractors depend on skilled employees, and wage inflation can pressure margins.

•

Broader small-cap market sentiment, interest rates, and investor appetite for unprofitable companies can also influence how the market values DLHC.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on DLHC

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show